BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
July 7, 2015
View Archived Issues
Hansen gets bump to start ARTISAN: Hansen Medical completes enrollment in initial cohort of ARTISAN clinical trial
Coming off a 5.07% bump in its shares last week, intravascular robotics specialist Hansen Medical (NASDAQ: HNSN) (Mountain View, Calif.) said it has completed enrollment in the initial evaluable cohort of its ARTISAN clinical trial.
Read More
Two patents invalidated: Fed Circuit: 'Experimental' manufacturing dooms patents
Read More
Latin America: British device aker looks to ride LatAm growth
Read More
Inside the Beltway: Economic impact report makes implicit argument for repeal of device tax
Read More
Report from Europe: EU Council readies CE mark reform for 'trialogue' negotiation
Read More
Daily M&A: Vygon Group buys Preouse to upgrade vascular access
Read More
Financings: Lantheus closes initial public offering,brings in nearly $66.7 million
Read More
World in Review: Lensar moves into Indian market, establishing Sharp Sight Centers
Read More
Products
Read More
Court Report: Enzo Biochem reaches $7.1M settlement with Luminex
Read More
People in Places
Read More
Briefly noted
Read More
MDD's Cardiology Extra
Read More
